Biophytis share price logo

Biophytis

OTC: BPTSY

Live

as on

Biophytis Stock Performance

as on January 1, 1970 at 11:00 am IST

  • $0.25
    $0.25

Biophytis share price movements today

Previous Close
-
Open
$0.25
Volume
3.0K
Market Cap
$18.2M
Day's Low - High
$0.25 - $0.25

Biophytis Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Biophytis Stock Fundamentals & Key Indicators

Check Biophytis market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$18.2M

EPS (TTM)

-8.3

Dividend Yield

0.00%

PE Ratio (TTM)

-0.02

Industry PE ratio

-3.98

PEG Ratio

-0.00

Return On Equity TTM

153.48%

Biophytis stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Biophytis with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Biophytis image
Biophytis
NA$18.2MNA-0.020.00%0.00%

Biophytis Quarterly Profit & Loss

All numbers in Millions USD

Dec 2019
Jun 2020
Dec 2020
Jun 2021
Dec 2021
Dec 2022
Jun 2023
Dec 2023
Jun 2024
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
0
0
0
-
-
Operating Income
-3
-3
-3
-5
-8
-17
-6
-7
-4
-4
EBITDA
-2
-3
-3
-5
-7
-11
-
-7
-4
-2
Interest Expense
0
0
0
0
0
0
1
0
-
0
Depreciation
0
0
0
0
0
0
-
0
0
0
Income Before Tax
-4
-6
-5
-6
-8
-11
-9
-9
-5
-3
Income Tax Expense
0
-
-
-
-
-
-
-
-
0
Net Income
-4
-6
-5
-6
-8
-11
-7
-9
-5
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Biophytis Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
-
0
-
Operating Income
-9
-13
-15
-13
-26
-23
-14
-8
EBITDA
-9
-13
-15
-13
-26
-22
-13
-8
Interest Expense
3
0
2
4
4
1
1
1
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-11
-14
-19
-25
-31
-24
-18
-10
Income Tax Expense
1
0
0
-
-
-
-1
-
Net Income
-11
-13
-18
-25
-31
-24
-17
-10
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Biophytis Quarterly Cash Flow

All numbers in Millions USD

Dec 2019
Jun 2020
Dec 2020
Jun 2021
Dec 2021
Dec 2022
Jun 2023
Dec 2023
Jun 2024
Jun 2025
Net Income
0
-6
-5
0
0
0
0
0
-5
-3
Operating Cash Flow
0
0
-4
0
0
0
0
0
-5
-3
Investing Cash Flow
-
0
-12,248
12
0
0
0
0
0
-
Financing Cash Flow
6
5,833
16,395
18
0
0
3
0
1
4
Change in Cash
2
2,344
-2,120
16
0
-8
-5
0
-1
1

Biophytis Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Jun 2025
Net Income
-11
-13
-17
-17
-31
-24
-17
-10
Operating Cash Flow
-8
-12
-15
-9
-23
-18
-12
-8
Investing Cash Flow
0
0
0
-12
12
0
0
0
Financing Cash Flow
25
6
7
21
29
6
7
3
Change in Cash
16
-5
-8
0
18
-12
-5
-5

About Biophytis

Biophytis S.A. is a clinical-stage biotechnology firm dedicated to developing therapeutic interventions that slow the degenerative processes associated with age and improve functional outcomes for patients. The company's innovative treatments work by targeting and activating vital biological resilience pathways. These mechanisms are designed to protect against and counteract various biological and environmental stresses, including inflammatory, oxidative, metabolic, and viral factors, which are known to contribute to age-related diseases. The company's leading investigational compound is BIO101, an orally administered small molecule. It is currently being developed for neuromuscular conditions such as sarcopenia, Duchenne muscular dystrophy (DMD), and obesity, as well as for managing severe respiratory failure in individuals afflicted with COVID-19. Biophytis is also advancing BIO201, another orally delivered small molecule, intended for the treatment of retinopathies, specifically dry age-related macular degeneration and Stargardt disease. The firm has a collaboration agreement with AFM-Telethon focused on the development of BIO101 for DMD. Established in 2006, Biophytis S.A. is headquartered in Paris, France.
OrganisationBiophytis
Headquarters14 avenue de l'Opéra, Paris, IF, 75001, FR
IndustryBiotechnology
CEOStanislas Veillet

Key Management of Biophytis

Name

Title

Mr. Christophe Courtillat

Chief Financial Officer

Mr. Waly Dioh Ph.D.

Chief Operating Officer

Dr. Pierre J. Dilda Ph.D.

Chief Scientific Officer

Dr. Rene Lafont

Scientific Advisor & Member of Scientific Advisory Board

Mr. Edouard Bieth

Chief Strategy Officer

Ms. . Teylan

Financial Controller

Mr. Stanislas Veillet Ph.D.

Chairman of the Board & CEO

FAQs

What is Biophytis's market capitalisation today?

Biophytis market capitalisation is $0.00T as on .

How to invest in Biophytis Stock (BPTSY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biophytis on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Biophytis Stock (BPTSY) from India?

Indian investors can start investing in Biophytis (BPTSY) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Biophytis stock (as per the Rupee-Dollar exchange rate as on ). Learn more about fractional shares .